Zobrazeno 1 - 10
of 200
pro vyhledávání: '"S. Pompe"'
Autor:
Ulrike S. Pompe-Alama
Publikováno v:
Frontiers in Psychology, Vol 9 (2018)
Externí odkaz:
https://doaj.org/article/588c07b276dc4320b20a2d19a509fcb2
Autor:
Andreas Becker, Philipp Gild, Mark-Andree Punke, Christian Meyer, Hang Yu, Valentin Maurer, Mara Kölker, Michael Rink, Phillip Marks, Armin Soave, Roland Dahlem, Margit Fisch, Tim A. Ludwig, Malte W. Vetterlein, Raisa S. Pompe
Publikováno v:
Urologia Internationalis. :1-8
Objective: The aim of the study was to compare procedural efficacy, early and late functional outcomes in holmium laser enucleation of the prostate (HoLEP) under spinal anesthesia (SA) versus general anesthesia (GA). Methods: We retrospectively revie
Autor:
Lara Franziska Stolzenbach, Markus Graefen, Zhe Tian, Carlotta Palumbo, Fred Saad, Stefano Luzzago, Raisa S. Pompe, Angela Pecoraro, Giuseppe Rosiello, Anne Sophie Knipper, Felix K.-H. Chun, Kevin C. Zorn, Shahrokh F. Shariat, Pierre I. Karakiewicz, Marina Deuker
Publikováno v:
Journal of the National Comprehensive Cancer Network. 18:1492-1499
Background: Misclassification rates defined as upgrading, upstaging, and upgrading and/or upstaging have not been tested in contemporary Black patients relative to White patients who fulfilled criteria for very-low-risk, low-risk, or favorable interm
Autor:
Alberto Briganti, Felix Preisser, Giorgio Gandaglia, Markus Graefen, Marco Bandini, Derya Tilki, Farid Arad, Hartwig Huland, Raisa S. Pompe, Pierre I. Karakiewicz, Francesco Montorsi
Publikováno v:
Prostate Cancer and Prostatic Diseases. 24:193-201
Objective: To investigate the oncologic safety of neurovascular bundles (NVB) preservation at radical prostatectomy (RP) in patients with high-risk and/or locally advanced prostate cancer (PCa). Material and methods: Within a two-institutional high-v
Autor:
Lars Budäus, Sami-Ramzi Leyh-Bannurah, Pierre I. Karakiewicz, Dirk Beyersdorff, Mykyta Kachanov, Tobias Maurer, Raisa S. Pompe, Su Jung Oh-Hohenhorst, Markus Graefen, Margit Fisch
Publikováno v:
World Journal of Urology. 39:81-88
Based on unfavorable oncological and functional outcomes of non-organ-confined (NOC) prostate cancer (PCa), defined as ≥ pT3, pN1 or both, we aimed to develop a NOC prediction tool based on multiparametric MRI-guided targeted fusion biopsy (TBx). A
Autor:
Derya Tilki, Felix Preisser, Reinhard Thamm, Raisa S. Pompe, Felix K.-H. Chun, Markus Graefen, Alessandra Siegmann, Dirk Böhmer, Volker Budach, Thomas Wiegel
Publikováno v:
Cancers, Vol 14, Iss 740, p 740 (2022)
Cancers; Volume 14; Issue 3; Pages: 740
Cancers
Cancers; Volume 14; Issue 3; Pages: 740
Cancers
Salvage radiotherapy improves oncologic outcomes in prostate cancer patients who develop biochemical recurrence after radical prostatectomy. However, the evidence on hard clinical endpoints is scarce. Within this study, we compare the long-term oncol
Autor:
Fred Saad, Pierre I. Karakiewicz, Shahrokh F. Shariat, Elio Mazzone, Raisa S. Pompe, Felix Preisser, Hartwig Huland, Derya Tilki, Sebastiano Nazzani, Hans Heinzer, Zhe Tian, Francesco Montorsi, Markus Graefen, Marco Bandini, Michele Marchioni
Publikováno v:
European Urology Focus. 5:807-814
Backround: Accurate life expectancy estimation is crucial in clinical decision-making including management and treatment of clinically localized prostate cancer (PCa). Objective: We hypothesized that Social Security Administration (SSA) life tables
Autor:
Felix K.-H. Chun, Georg Salomon, Raisa S. Pompe, Hartwig Huland, Derya Tilki, Markus Graefen, Felix Preisser, Alexander Heinze
Publikováno v:
European Urology. 76:106-114
Persistent prostate-specific antigen (PSA) represents a poor prognostic factor for recurrence after radical prostatectomy (RP).To investigate the impact of persistent PSA at 6wk after RP on long-term oncologic outcomes and to assess patient character
Publikováno v:
European Urology. 75:896-900
The impact of biochemical recurrence (BCR) after radical treatment of prostate cancer on oncological outcomes remains unclear. A new European Association of Urology BCR risk stratification (low and high risk) has been proposed. To validate these risk
Autor:
Felix Preisser, Valentin Maurer, Hartwig Huland, Derya Tilki, Alexander Haese, Markus Graefen, Philipp Mandel, Raisa S. Pompe, Felix K.-H. Chun
Publikováno v:
World Journal of Urology. 38:95-101
Age is an important prognostic factor for functional and oncological outcomes after radical prostatectomy (RP). Considering the long life-expectancy of young patients (≤ 45 years), it remains important to examine their outcomes. Of 16.049 patients